Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib may effectively treat folliculitis decalvans.

Tisseel shows promise for bone graft stabilization but needs more clinical trials to confirm its effectiveness.

Targeted testing for telogen effluvium patients can save healthcare costs.

Low levels of ferritin and vitamin B12 are common in women with telogen effluvium, but the link between nutrient deficiencies and the condition is not clear.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

The TO-TF copolymer strengthens damaged hair effectively and sustainably.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

The document cannot be parsed.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Topical tofacitinib may help regrow hair in children with alopecia totalis.